Association Studies on Gut and Lung Microbiomes in Patients with Lung Adenocarcinoma

Yaqiong Guo,Wenjie Yuan,Na Lyu,Yuanlong Pan,Xiaoqing Cao,Yuxuan Wang,Yi Han,Baoli Zhu

DOI: https://doi.org/10.3390/microorganisms11030546

IF: 4.5

2023-02-21

Microorganisms

Abstract:Lung adenocarcinoma (LADC) is a prevalent type of lung cancer that is associated with lung and gut microbiota. However, the interactions between these microbiota and cancer development remain unclear. In this study, a microbiome study was performed on paired fecal and bronchoalveolar lavage fluid (BALF) samples from 42 patients with LADC and 64 healthy controls using 16S rRNA gene amplicon and shotgun metagenome sequencing, aiming to correlate the lung and gut microbiota with LADC. Patients with LADC had reduced α-diversity in the gut microbiome and altered β-diversity compared with healthy controls, and the abundances of Flavonifractor, Eggerthella, and Clostridium were higher in the gut microbiome of LADC patients. The increased abundance of microbial species, such as Flavonifractor plautii, was associated with advanced-stage LADC and a higher metastasis rate. Phylogenetically, Haemophilus parainfluenzae was the most frequently shared taxon in the lung and gut microbiota of LADC patients. Gut microbiome functional pathways involving leucine, propanoate, and fatty acids were associated with LADC progression. In conclusion, the low diversity of the gut microbiota and the presence of H. parainfluenzae in gut and lung microbiota were linked to LADC development, while an increased abundance of F. plautii and the enriched metabolic pathways could be associated with the progression of LADC.

microbiology

What problem does this paper attempt to address?

### Problems the Paper Attempts to Solve

This paper aims to explore the association between the gut and lung microbiomes in patients with lung adenocarcinoma (LADC). Specifically, the researchers hope to reveal the relationship between these microbiomes and the occurrence and development of lung adenocarcinoma by analyzing paired fecal and bronchoalveolar lavage fluid (BALF) samples. The main issues of the study include:

1. **Changes in the diversity of gut and lung microbiomes**:
- Does the gut microbiome of lung adenocarcinoma patients show a reduction in diversity?
- Is there a significant change in the composition of the patients' gut and lung microbiomes?

2. **Changes in the abundance of specific bacterial species**:
- Which specific bacterial species have increased abundance in the gut and lung microbiomes of lung adenocarcinoma patients?
- Is the increase in these bacterial species related to the progression and metastasis of the disease?

3. **Shared components of the gut and lung microbiomes**:
- Are there shared bacterial species between the gut and lung microbiomes?
- What role do these shared bacterial species play in the occurrence and development of lung adenocarcinoma?

4. **Changes in metabolic pathways**:
- Are the functional pathways of the gut microbiome related to the development of lung adenocarcinoma?
- Are specific metabolic pathways associated with the progression of the disease?

By exploring these issues, the researchers hope to better understand the role of the gut and lung microbiomes in lung adenocarcinoma, thereby providing new clues for the diagnosis and treatment of the disease.